Pinsent Masons advises Beijing Jangho on acquistion of Sundart International fitting-out business

06 Jul 2012 | 12:50 pm |

International law firm Pinsent Masons has advised Beijing Jangho Curtain Wall Co., Ltd. (Beijing Jangho) on its acquisition of an 85% stake in Sundart Holdings Limited, a subsidiary of Hong Kong Stock Exchange listed Sundart International Holdings Limited (Sundart International), for HK$493 million (£40 million).

Head quartered in Beijing China, Beijing Jangho is a large-scale provider of façade solutions and is listed on the Shanghai Stock Exchange. The company operates a manufacturing and full installation business in both Chinese domestic and international markets. Renowned company projects include Terminal 3 of Beijing Capital Airport, the headquarters of China National Petroleum Corporation, China World Trade Centre Phase Ⅲ, Shanghai International Financial Centre, Marina Bay Sands Integrated Resort in Singapore, Abu Dhabi Financial Centre and Dubai Infinity Tower. The acquisition of the fitting-out business of Sundart International forms part of Beijing Jangho’s strategy to expand its business further into interior design.

 The Pinsent Masons team advising on the deal was led by Corporate Partner Kenneth Chong, assisted by Senior Associate Sylvia Zee and Counsel Jackie Liu in the Hong Kong and Beijing offices.

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

Pinsent Masons advises ALK Capital on its acquisition of Burnley FC

Multinational law firm Pinsent Masons has advised ALK Capital on the acquisition of Burnley Football Club.

Pinsent Masons advises Unbound on financing in fitness start-up VAHA

Pinsent Masons has advised Unbound on its investment in etone Motion Analysis GmbH (VAHA), a manufacturer of smart digital mirrors.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts